期刊文献+

低级别胶质瘤SLC12A5的表达及临床意义的生信分析

Clinical meanings of SLC12A5 expression in low-grade glioma based on analysis of bioinformatics methods
下载PDF
导出
摘要 目的探讨溶质载体家族12成员5(SLC12A5)在低级别胶质瘤(LGG)中的表达及临床意义。方法利用GEPIA数据库分析SLC12A5在LGG的表达以及SLC12A5表达与LGG病人预后的关系;通过GEMEMANIA和SDTRING数据库构建SLC12A5的相互作用网络;筛选50个与SLC12A54存在强相关关系的基因并进行功能富集分析。结果SLC12A5在LGG组织中表达显著下调,Kaplan-Meier生存曲线显示SLC12A5低表达与LGG病人不良生存预后有关。相互作用网络结果显示SLC12A5可能与STK39存在相互作用关系。功能富集分析发现,SLC12A5及其共表达基因主要参与化学突触传递、突触小泡周期、认知、细胞连接组织、突触小泡回收以及体液水平的调节等生物学过程。结论SLC12A5在LGG中呈低表达,与病人不良预后相关。 Objective To analyze the expression of solute carrier family 12 member 5(SLC12A5)in low-grade glioma(LGG)based on bioinformatics.Methods The expression of SLC12A5 in LGG and the relationship between expression of SLC12A5 and prognosis of LGG patients were analyzed by GEPIA database.The interaction network of SLC12A54 was constructed by GEMEMANIA and SDTRING databases.Functional enrichment analysis of 50 genes with strong correlation with SLC12A54 was perdormed by Metascape databases.Results SLC12A5 was significantly downregulated in LGG tissues.Kaplan-Meier survival curves showed that low expression of SLC12A5 was associated with poorer survival of LGG patients.Interaction network results indicated a possible interaction between SLC12A5 and STK39.Functional enrichment analysis revealed that SLC12A5 and its co-expressed genes are mainly involved in biological processes such as chemical synaptic transmission,synaptic vesicle cycle,cognition,cellular junctional organization,synaptic vesicle recycling,and regulation at the somatic level.Conclusions SLC12A5 is lowly expressed in LGG tissues and correlated with poor clinical prognosis of LGG patients.
作者 张钧 宋国智 常成 ZHANG Jun;SONG Guo-zhi;CHANG Cheng(Department of Neurosurgery,Handan Central Hospital,Handan 056002,China)
出处 《中国临床神经外科杂志》 2022年第4期269-273,共5页 Chinese Journal of Clinical Neurosurgery
关键词 低级别胶质瘤 溶质载体家族12成员5 预后 基因表达 生物信息学 Low-grade glioma Solute carrier family 12 member 5 Gene expression Bioinformatics
  • 相关文献

参考文献1

二级参考文献25

  • 1Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
  • 2Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-274.
  • 3Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-1113.
  • 4Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472:90-94.
  • 5Kreso A, O'Brien CA, van Galen P, et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 2013; 339:543-548.
  • 6Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013; 501:338-345.
  • 7Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194:23-28.
  • 8Sakurazawa N, Tanaka N, Onda M, Esumi H. Instability of X chromosome methylation in aberrant crypt foci of the human colon. Cancer Res 2000; 60:3165-3169.
  • 9Beutler E, Collins Z, Irwin LE. Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N Engl J Med 1967; 276:389-391.
  • 10Hsu SH, Luk GD, Krush AJ, Hamilton SR, Hoover HH Jr. Multiclonal origin of polyps in Gardner syndrome. Science 1983; 221:951-953.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部